Drug intelligence / Profile preview

IGEN-0206

Development stage: Preclinical
Lead developer: IGEN Biotech
Modality: Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration: Oral

Overview

IGEN-0206 is a **dietary supplemental nutritional product** being evaluated for its impact on quality of life, nutritional status, and modulation of the gut microbiota in patients with metastatic non-small cell lung cancer (NSCLC)[7][5][3]. It functions as an **oral probiotic-based therapy** aimed at beneficially altering gut microbial composition and metabolites, which may have immunomodulatory effects and support general health and nutritional status in cancer patients. The precise bacterial strains or nutritional components of IGEN-0206 have not been publicly detailed[3][5][7].

Brand names: IGEN-0206IGEN0206IGEN 0206
Other names: IGEN-0206IGEN0206IGEN 0206

Beyond the preview

Go deeper on IGEN-0206.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IGEN-0206.

Explore the full profile